Kim Soo-Hyun, Chang Mi-Yoon
Department of Biomedical Science, Graduate School of Biomedical Science and Engineering, Seoul 04763, Republic of Korea.
Biomedical Research Institute, Hanyang University, Seoul 04763, Republic of Korea.
Int J Mol Sci. 2023 Aug 7;24(15):12528. doi: 10.3390/ijms241512528.
Brain organoids are three-dimensional (3D) structures derived from human pluripotent stem cells (hPSCs) that reflect early brain organization. These organoids contain different cell types, including neurons and glia, similar to those found in the human brain. Human brain organoids provide unique opportunities to model features of human brain development that are not well-reflected in animal models. Compared with traditional cell cultures and animal models, brain organoids offer a more accurate representation of human brain development and function, rendering them suitable models for neurodevelopmental diseases. In particular, brain organoids derived from patients' cells have enabled researchers to study diseases at different stages and gain a better understanding of disease mechanisms. Multi-brain regional assembloids allow for the investigation of interactions between distinct brain regions while achieving a higher level of consistency in molecular and functional characterization. Although organoids possess promising features, their usefulness is limited by several unresolved constraints, including cellular stress, hypoxia, necrosis, a lack of high-fidelity cell types, limited maturation, and circuit formation. In this review, we discuss studies to overcome the natural limitations of brain organoids, emphasizing the importance of combinations of all neural cell types, such as glia (astrocyte, oligodendrocytes, and microglia) and vascular cells. Additionally, considering the similarity of organoids to the developing brain, regionally patterned brain organoid-derived neural stem cells (NSCs) could serve as a scalable source for cell replacement therapy. We highlight the potential application of brain organoid-derived cells in disease cell therapy within this field.
脑类器官是源自人类多能干细胞(hPSC)的三维(3D)结构,反映了早期大脑组织。这些类器官包含不同的细胞类型,包括神经元和神经胶质细胞,类似于在人类大脑中发现的细胞类型。人类脑类器官为模拟在动物模型中未得到充分体现的人类大脑发育特征提供了独特的机会。与传统细胞培养和动物模型相比,脑类器官能更准确地呈现人类大脑的发育和功能,使其成为神经发育疾病的合适模型。特别是,源自患者细胞的脑类器官使研究人员能够在不同阶段研究疾病,并更好地理解疾病机制。多脑区组装体有助于研究不同脑区之间的相互作用,同时在分子和功能特征方面实现更高水平的一致性。尽管类器官具有有前景的特征,但其效用受到一些未解决的限制,包括细胞应激、缺氧、坏死、缺乏高保真细胞类型、成熟受限和回路形成。在这篇综述中,我们讨论了克服脑类器官自然局限性的研究,强调了所有神经细胞类型组合的重要性,如神经胶质细胞(星形胶质细胞、少突胶质细胞和小胶质细胞)和血管细胞。此外,考虑到类器官与发育中大脑的相似性,区域模式化的脑类器官衍生神经干细胞(NSC)可作为细胞替代疗法的可扩展来源。我们强调了脑类器官衍生细胞在该领域疾病细胞治疗中的潜在应用。